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In the present research, the steroidal anti-asthmatic drug beclomethasone dipropionate was subjected 
to microbial biotransformation by Aspergillus niger. Beclomethasone dipropionate was transformed 
into various metabolites first time from microbial transformation. New drug metabolites produced 
can act as new potential drug molecules and can replace the old drugs in terms of safety, efficacy, and 
least resistance. They were purified by preparative thin layer chromatography technique, and their 
structures were elucidated using modern spectroscopic techniques, such as 13C NMR, 1H NMR, HMQC, 
HMQC, COSY, and NOESY, and mass spectrometry, such as EI-MS. Four metabolites were purified: 
(i) beclomethasone 17-monopropionate, (ii) beclomethasone 21-monopropionate, (iii) beclomethasone, 
and (iv) 9beta,11beta-epoxy-17,21-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-propionate.
Uniterms: Anti-asthmatics. Aspergillus niger/use in biotransformation. Beclomethasone dipropionate/
microbial biotransformation. Steroids/microbial transformation. Biotransformation.
Na pesquisa presente o fármaco esteróide antiasmático dipropionato de beclometasona foi submetido à 
biotransformação microbiana pelo Aspergillus niger. O dipropionato de beclometasona foi transformado, 
pela primeira vez, em metabólitos variados por biotransformação microbiana. Novos metabólitos do 
fármaco produzidos podem agir como novas moléculas potenciais e podem substituir os fármacos antigos 
em questão de segurança, eficácia e mínima resistência. Eles foram purificados por cromatografia em 
camada delgada preparativa e as suas estruturas foram elucidadas usando técnicas espectroscópicas 
modernas, como 13C NMR, 1H NMR; HMQC; HMQC; COSY, NOESY e espectrometria de massas, 
por exemplo, EI-MS. Purificaram-se quatro metabólitos, denominados (i) 17-monopropionato de 
beclometasona; (ii) 21-monopropionato de beclometasona: (iii) beclometasona e (iv) 21-propionato de 
9beta,11beta-epoxi-17,21-diidroxi-16beta-metilpregna-1,4-dieno-3,20-diona.
Unitermos: Antismáticos. Aspergillus niger/uso em biotransformação. Dipropionato de beclomentasona/
biotransformação microbiana. Esteróide/biotransformação microbiana. Biotransformação.
INTRODUCTION
Development of efficient, environmental friendly 
and cost-effective routes to synthesize fine chemicals 
is the need of the day. Biotransformation had been an 
exciting area of research for decades, and enzymes 
from various sources, that is, microorganisms, animal, 
and plant cells, have been employed for carrying out 
reactions at chemically inaccessible positions of organic 
compounds (Zafar et al., 2012). Microbial transformation 
of steroids has been extensively investigated (Donova, 
Egorova, 2012), and various hydroxylated derivatives 
have been produced on large scale (Abourashed, Clark, 
Hufford, 1999). Microbial transformation of steroids has 
been extensively employed for the synthesis of steroidal 
drugs, both at laboratory and industrial levels (Choudhary 
et al., 2012; Choudhary et al., 2011; Choudhary et al., 
2010; Al-Aboudi et al., 2009; Choudhary et al., 2009; 
Choudhary et al., 2007; Devkota et al., 2007). In 
modern drug discovery process, generation of libraries 
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of bioactive compounds with diverse structures plays 
an important role (Tong, Dong, 2009). Aspergillus niger 
is classified under Aspergillus subgenus Circumdati, 
segment Nigri had an ability to convert the steroidal 
compounds into various structural derivatives, that is, 
methyl cholate and progesterone was converted into 
various metabolites (Al-Aboudi et al., 2009; Fouad et 
al., 2009). Beclomethasone dipropionate (1) is a drug 
having steroid nucleus categorized under corticosteroids 
(Navaratnam et al., 2009). It is prescribed by physicians 
for the remedy of bronchial asthma in individuals 
needing continuous management (Navaratnam et al., 
2009), seasonal and perennial rhinitis (Chervinsky, 
1996), and inhibition of reoccurrence of nasal polyps. It 
is used as nasal inhalation (Kanazawa et al., 2003), orally 
and topically (Fascì et al., 2012). Glucocorticosteroids 
have strong anti-inflammatory activities (Aubier et al., 
2006). This drug (BDP) was a significant substance in the 
pharmaceutical industry as an anti-inflammatory agent 
(Fascì et al., 2012).
MATERIALS AND METHODS
General
Beclomethasone dipropionate (1) was purchased 
from Beijing Mesochem Technology Co. Ltd., China. Thin 
layer chromatography was carried out on precoated plates 
(Silica gel, Merck, PF254). Column chromatography (CC) 
was performed using silica gel (E. Merck, Germany). 1H 
and 13C-NMR spectra were recorded in CDCl3 on Bruker 
Avance-NMR spectrometers. The chemical shifts (δ 
values) are presented in ppm, and the coupling constants 
(J values) are in Hertz. JEOL (Japan) JMS-600H mass 
spectrometer was used for recording EI-MS in m/z.
Microbial Culture
Aspergillus niger FCBP-764 was purchased from 
First Fungal Culture Bank of Pakistan (FCBP) grown 
on Saboraud dextrose agar (SDA) England. The culture 
medium for A. niger was prepared by dissolving glucose 
(40 g), yeast extract (20 g), peptone (20 g), NaCl (20 g), 
KH2PO4 (20 g), and glycerol (20 mL) in distilled water 
(4.0 L).
Fermentation of beclomethasone dipropionate (1) 
and purification of metabolites
In the experiment, we employed 40 Erlenmeyer 
flasks (250 mL) for the distribution of 4000 mL media in a 
way such that every flask comprises 100 mL media. Stage 
II fermentation procedure was used entirely for microbial 
transformation studies (Sepuri, Maravajhala, 2009). 
Liquid cultures were made in stage I by inoculating the 
spores of fungi from the mycelia on the Saboraud Dextrose 
Agar slants into the three Erlenmeyer flasks (250 mL), 
which comprises 100 mL of autoclaved medium. The 
cotton plugged flasks were then placed on rotary shaker at 
114 rpm for fungal growth for 6 to 9 days. Stage II cultures 
were organized by shifting small quantities of the stage I 
mycelia into 40 conical flasks each comprising 100 mL 
sterilized medium for three days in cotton plugged flasks 
on rotary shaker. After observing good growth on the 
third day, substrate 1 g beclomethasone dipropionate was 
dissolved in 20 mL chloroform and was equally distributed 
among all the flasks such that 25 mg or 0.5 mL per flask), 
which were then placed on rotary shaker at 25-30 °C for 
more than 12 days. After accomplishment of fermentation, 
the fungal mass was separated, and filtrate was extracted 
with n-butanol.
The extract (organic phase) was desiccated over 
anhydrous Na2SO4, evaporated under vacuum pressure 
in rotary evaporator to obtain brown gummy crude 
extract, which was put to analysis through various 
chromatographic techniques.
Slurry of this crude extract was prepared in a petri 
dish. A wide width column was made and packed with 
silica gel and solvent chloroform. Slurry was loaded on 
to the column while carefully maintaining its surface 
and cotton was placed onto the slurry for comforting its 
surface stability throughout the procedure. At this time, 
slurry was eluted with gradient methanol/chloroform 
solvent system starting with 200 mL of chloroform and 
then 2.5%, 5%, 7.5%, 10%, 15%, 20%, and 25% methanol/
chloroform (200 mL). Fractions obtained were desiccated 
in vacuum hood, and these were subjected to thin layer 
chromatography. Fractions showing the same metabolites 
on thin layer chromatography were compiled for future 
processes. Four fractions were achieved from the main 
column after compilation. Furthermore, these 4 fractions 
were engaged in preparative thin layer chromatography 
for further purification.
Fractions 1, 2, 3, and 4 were run on preparative 
TLC for purification because of its low quantity. All the 
pure samples were subjected to NMR investigations for 
structure elucidation.
RESULTS
Fermentation of beclomethasone dipropionate with 
Aspergillus niger for 12 days produced four compounds 
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(2-5). The structure of identified biotransformation 
products of beclomethasone dipropionate (1) by 
Aspergillus niger are given in Figure 1.
Beclomethasone 17-monopropionate (2)
Colorless amorphous solid.  Mol.  formula: 
C25H33ClO6, Mol. Wt. 464.5 g/mol, HREI-MS m/z (mol. 
formula):465.1 (C25H33ClO6), 1H- (400 MHz, CDCl3): 
Table I and 13C-NMR (100 MHz, CDCl3): Table II.
Beclomethasone 21-monopropionate (3)
Colorless amorphous solid. Mol.formula:C25H33ClO6, 
Mol. Wt. 464.5g/mol, HREI-MS m/z (mol. formula): 
464.9 (C25H33ClO6), 1H- (400 MHz, CDCl3): Table I and 
13C-NMR (100MHz, CDCl3): Table II.
Beclomethasone (BOH)(4)
Colorless amorphous solid .Mol.  formula: 
C22H29ClO5, Mol. Wt: 409.3 g/mol, HREI-MS m/z (mol. 
formula):409.1 (C22H29ClO5).1H- (400 MHz, CDCl3): 
Table I and 13C-NMR (100 MHz, CDCl3): Table II.
FIGURE 1 – Products resulting from the biotransformation of 
beclomethasone dipropionate (1) by Aspergillus niger.
9 beta, 11beta-epoxy-17, 21-dihydroxy-16 
beta-methylpregna-1,4-diene-3,20-dione 
21-propionate (5)
Compound (5) was purified on preparative 
TLC as a colorless solid. Mol. formula: C25H32O6, 
Mol. Wt.431 g/mol, HREI-MS m/z (mol. formula): 429.5 
(C25H32O6), 1H- (400 MHz, CDCl3): Table I and 13C-NMR 
(100 MHz, CDCl3): Table II.
Compound (2) had an elemental composition 
C25H33ClO6, deduced through HREI-MS (M+=m/z 465.1) 
and molecular weight is 464.5 g/mol. The compound 
showed fluorescence beneath UV light. This suggested 
that the compound has unsaturated carbonyl system. The 
13C- and 1H-NMR spectra showed the presence of the 
double bond between C-1/C-2 and C-4/C-5. The 1H- and 
13C-NMR data for metabolite (2) is given in Tables I and II, 
respectively. The 13C-NMR spectrum (100 MHz, CDCl3) 
(including BB, dept 90, and dept 135) of (2) showed the 
resonances for 4 methyl, 6 methylene, 7 methine, and 
8 quaternary carbons. 17 α propionate CH3 and 17 α 
propionate CH2 group present at position 17.
Mass spectra indicated that the mass of this 
compound is 465.1 Da, which is 55.94 mass units less 
than the substrate (521.04) and also showed the removal 
of COC2H4 (56 mass units). The net 56 mass units are less 
than the substrate. So metabolite (2) was thus identified 
as beclomethasone 17-monopropionate.
Compound (3) had an elemental composition 
C25H33ClO6, deduced through HREI-MS (M+=m/z 464.9), 
and molecular weight is 464.5 g/mol. The compound 
showed fluorescence beneath the UV light. This suggested 
that the compound has unsaturated carbonyl system. The 
13C- and 1H-NMR spectra showed the presence of the 
double bond between C-1/C-2 and C-4/C-5. The 1H- and 
13C-NMR data for metabolite (3) is given in Tables I and 
II, respectively. The 13C-NMR spectrum (100MHz, CDCl3) 
(including BB, dept 90, and dept135) of (3) showed the 
resonances for 4 methyl, 6 methylene, 7 methine, and eight 
quaternary carbons and presence of 21 propionate CH3 
with 21 propionate CH2 at position 21.
Mass spectra indicated that the mass of this 
compound is 464.9 Da, which is 56.1 mass units less than 
the substrate (521.04) and also showed the removal of 
COC2H4 (56 mass units). The net 56 mass units are less 
than the substrate. So metabolite (3) was thus identified 
as beclomethasone 21-monopropionate.
Compound (4) had an elemental composition 
C22H29ClO5, deduced through HREI-MS (M+=m/z 409.1), 
and molecular weight is 408.5 g/mol. The compound 
showed fluorescence beneath the UV light. This suggested 
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that the compound has unsaturated carbonyl system. The 
13C- and 1H-NMR spectra showed the presence of the 
double bond between C-1/C-2 and C-4/C-5. The 1H- and 
13C-NMR data for metabolite (4) is given in Tables I and 
II, respectively. The 13C-NMR spectrum (100MHz, CDCl3) 
(including BB, dept 90, and dept135) of (4) showed the 
resonances for 3 methyl, 5 methylene, 7 methine, and 7 
quaternary carbons. At position 17 α, a hydroxyl group 
is present, and at position 21, a hydroxyl group is again 
present.
Mass spectra indicated that the mass of this compound 
is 409.1 Da, which is 111.94 mass units less than the 
substrate (521.04) and also showed the removal of COC2H4 
(56 mass units) and again COC2H4 (56 mass unit). The net 
112 mass units are less than the substrate. So metabolite (4) 
was thus identified as beclomethasone (BOH).
Compound (5) had an elemental composition 
C25H32O6, deduced through HREI-MS (M+=m/z 429.5), 
and molecular weight is 431 g/mol. The compound showed 
fluorescence beneath the UV light. This suggested that the 
compound has unsaturated carbonyl system. The 13C- and 
1H-NMR spectra showed the presence of the double bond 
between C-1/C-2 and C-4/C-5. The 1H- and 13C-NMR data 
for metabolite (5) is given in Tables I and II, respectively. 
The 13C-NMR spectrum (100 MHz, CDCl3) (including 
BB, dept 90, and dept135) of (5) showed the resonances 
for 4 methyl, 6 methylene, 7 methine, and 8 quaternary 
carbons. Also at position 21, methyl and methylene group 
are present, and at position 17, α hydroxyl group is present. 
11 β OH is also removed, and no spectral data for 17 
COC2H5 at position carbon 17 instead of 17α-hydroxyl 
group is present. At position of carbon 11, the resonance 
of CH is present instead of CH2 and provides the data of 
oxygen atom, which also gives resonance with carbon 9 
position. Its mean chlorine atom is removed, and epoxy 
bond is produced between carbon 9 and 11 positions.
TABLE I - 1H- (400 MHz, CDCl3) Chemical shift assignments of all metabolites produced (2, 3, 4, 5)
Carbon no. Compound (2) 
δH (J = Hz)
Compound (3) 
δH (J = Hz)
Compound (4) 
δH (J = Hz)
Compound (5) 
δH (J = Hz)
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
 
22 
23 
24 
16 β CH3 
11 β OH 
17 α OH 
21 OH
7.17 (d 10.1) 
6.31 (dd 10.1, 1.8) 
----------------- 
6.07 (s) 
------------------ 
2.02,m; 1.92,m 
1.43,m; 1.18,m 
1.73, m 
----------------- 
----------------- 
3.48 (s) 
1.65, m; 1.40, m 
---------------- 
1.41,m 
2.14,m; 1.86,m 
1.97, m 
----------------- 
0.95 (s) 
1.63 (s) 
------------------ 
4.01 d, 4.03 d 
(16.7, 16.7) 
--------------- 
2.37 (q 7.5) 
1.15 (t 7.5) 
1.38 (d 7.4) 
2.4 (d 3.7) 
---------- 
----------
7.25 (d 10.3) 
6.26 (dd 10.3, 2.2) 
---------------- 
6.09 (s) 
------------------ 
2.03,m; 1.94,m 
1.43,m; 1.18,m 
1.73, m 
----------------- 
----------------- 
3.48 (s) 
1.65, m; 1.40m 
---------------- 
1.41, m 
2.19,m; 1.89,m 
2.48, m 
----------------- 
1.07 (s) 
1.68 (s) 
------------------ 
4.81 d, 4.98 d 
(17.6, 17.6) 
-------------- 
2.49 (dq 1.7, 7.6) 
1.16 (t 7.6) 
1.19 (d 7.4) 
1.4 (d 2.6) 
-------------- 
--------------
7.31 (d 10.0) 
6.24 (dd 10.0, 1.8) 
----------------- 
6.01 (s) 
--------------- 
2.02,m; 1.92,m 
1.41,m; 1.16,m 
1.71, m 
----------------- 
----------------- 
3.46 (s) 
1.63, m; 1.38m 
---------------- 
1.39, m 
2.13,m; 1.87,m 
1.91, m 
----------------- 
0.99 (s) 
1.64 (s) 
--------------- 
4.13 (dd 19.2, 5.9) 
4.32 (dd 19.4, 5.7) 
------------- 
------------ 
------------ 
1.09 (d7.2) 
5.35 (d 4.7) 
5.45 (s) 
4.6 (t 5.6)
6.67 (d 10.2) 
6.23 (dd 10.2, 1.8) 
---------------- 
6.18 (bs) 
---------------- 
2.03,dd; 1.90,td 
1.40,m; 1.19,m 
1.74, m 
----------------- 
----------------- 
3.28 (s) 
1.64, m; 1.39m 
---------------- 
1.38, m 
2.16,m; 1.89,m 
1.88, m 
----------------- 
0.97 (s) 
1.48 (s) 
------------------ 
4.83 (dd 17.3) 
4.94 (dd 17.3) 
--------------- 
2.49 (q 7.7) 
1.17 (t 7.7) 
1.18 (d7.4) 
----------- 
1.9 (s) 
-----------
NOTE: Assignments based on COSY, HMBC, and HMQC spectra. Assignments shown without multiplicity and multiplet.
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TABLE II - 13C-NMR(100 MHz, CDCl3) data of compounds (2, 3, 4, and 5)
Carbon no Compound (2) 
δC
Compound (3) 
δC
Compound (4) 
δC
Compound (5) 
δC
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24
148.9 
127.2 
185.3 
125.1 
168.5 
32.7 
28.9 
36.9 
72.9 
63.4 
70.1 
34.8 
46.7 
43.1 
32.7 
46.7 
94.1 
17.5 
27.7 
204.5 
67.1 
173.5 
27.7 
10.1
149.5 
128.2 
185.8 
124.3 
168.2 
32.7 
29.2 
38.3 
73.2 
62.7 
70.1 
35.3 
47.3 
42.2 
32.2 
36.3 
92.2 
17.1 
28.2 
211.3 
66.4 
173.4 
27.5 
9.5
149.6 
128.4 
185.6 
124.4 
168.3 
32.3 
29.2 
38.1 
73.5 
62.8 
70.2 
35.1 
47.1 
42.6 
32.4 
38.4 
92.5 
17.3 
28.3 
211.4 
66.5 
------- 
------- 
-------
153.5 
128.9 
185.8 
124.9 
166.4 
29.8 
31.6 
34.6 
69.3 
44.8 
64.4 
33.8 
49.6 
47.2 
32.4 
38.9 
91.3 
16.9 
23.9 
205.4 
68.7 
172.9 
28.5 
10.6
Mass spectra indicated that the mass of this 
compound is 429.5 Da, which is 91.54 mass units less 
than the substrate (521.04 and also showed the removal 
of COC2H4 (56 mass units) and chlorine atom (35.5 
mass unit). The net 91.5 mass units are less than the 
substrate. So metabolite (5) was thus identified as 9beta, 
11beta-epoxy-17, 21-dihydroxy-16beta-methylpregna-1, 
4-diene-3, 20-dione 21-propionate.
DISCUSSION
The potential route of synthesis of these compounds is 
as follows. Compound (5) has only been reported chemically 
by Van Leusen in 1994. In this approach, the starting 
material was 21-acetoxy-4, 9 (11), 16-pregnatriene-3, 
20-dione, leading to four-stepped chemical reaction 
requiring a variety of chemicals and conditions resulting 
in the formation of the epoxy derivative, whereas 
in biotransformation, a number of reactions can be 
accomplished in one container, and reactions under mild 
conditions was required even at room temperature. As 
there was no hazardous substances used for the production 
of these metabolites so it could be denominated as green 
chemistry while chemical synthesis involved hazardous 
chemicals lead to the environmental pollution. Aspergillus 
niger had an ability to hydrolyze the compounds because 
of the presence of hydrolase enzymes in its enzyme system 
(El-Refai et al., 2012). Two reactions were involved in 
the synthesis: ester hydrolysis and loss of HCl to form an 
epoxide shown in Figure 1. Compounds (2, 3, and 4) were 
reported only by human metabolism (Foe et al., 1997). The 
four compounds produced were two monopropionates, 
that is, beclomethasone 17-monopropionate (2) and 
beclomethasone 21-monopropionate (3), one epoxy (5), 
and one depropionated derivative (4). Compound (4) 
was already reported as pharmacologically inactive, and 
compound (2) was pharmacologically active (Nave, Fisher, 
McCracken, 2007), whereas compound (3) was reported 
as pharmacologically inactive compound (Würthwein, 
Rohdewald, 1990). It is expected that the new metabolites 
formed may have more anti-inflammatory activity; better 
therapeutic profile, safety, and efficacy; and least resistance 
and can be employed in the treatment of asthma as that of 
the parent compound.
In the present study, we could produce these 
compounds outside the body, which showed the definite 
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potential of the emerging route of metabolism of drug as 
well as new drug discovery from the existing one.
CONCLUSION
Microbial biotransformation of beclomethasone 
dipropionate by Aspergillus niger resulted in four 
metabolites produced first  t ime from microbial 
biotransformation, which showed the potential of this 
route as a model to the study of the metabolism of 
beclomethasone dipropionate in mammalian and also 
illustrated the enzymatic potential of Aspergillus niger. 
The four compounds included two monopropionates, one 
epoxy, and one depropionated derivative. Depropionated 
metabolite was already reported as pharmacologically 
inactive, whereas beclomethasone 17-monopropionated 
was pharmacologically active, and beclomethasone 
21-monopropionated was pharmacologically active. It is 
expected that the epoxide derivative may have more anti-
inflammatory activity than the parent compound.
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